Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Partner operating in the Health Care space. If you think a Partner is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Geoffrey D Fink
Partner, Head of Investments of Incentrum Group
Geoffrey Fink has served as Partner, Head of Investments at Incentrum Group since co-founding the firm in February 2017. He previously led Delta Partners Capital Limited’s investment business. His professional career includes leading significant buyout and growth capital transactions in the telecoms, media and digital (TMD) and consumer sectors. Geoffrey has a strong track record of significant value creation for his investors, including investments in challenging emerging markets environments. Prior to joining Delta Partners, Geoffrey was at TPG Capital based in Moscow, where he headed the Eurasia (Russia/CEE/Israel/Turkey) team for three years. Before that, he was based in London and Paris with TPG for seven years, during which time he played a leading role in several telecom infrastructure investments and also led coverage of the consumer goods and airline transportation sectors. Prior to joining TPG, Geoffrey was a Senior Vice President of Security Capital Group, based in London. He also served as a consultant and manager at McKinsey & Company in London and held roles in investment banking with Goldman Sachs and PaineWebber. Geoffrey is a member of the New York Bar and has served on the Board of Directors of a number of public companies including Gemplus International SA, Gemalto NV, Eutelsat Communications SA, and Eden Springs Ltd., as well as having been a director of numerous private companies. Geoffrey received a J.D., magna cum laude, from Harvard Law School, an M.A.L.D. from the Fletcher School of Law and Diplomacy and a Bachelor’s of Arts, summa cum laude, from Yale University. He speaks fluent English, French and Spanish, and is actively engaged with a number of educational and charitable institutions.
Follow Geoffrey D Fink:
About Delta Partners Capital Limited, Funding Circle, Funding Circle, Grain & Barrel Spirits, Incentrum Group, Vennpoint Limited: Incentrum Group is a merchant bank focused on the Healthcare, Life/Material Science, and Technology Industries.
Immo Rupf
Partner of Cinven
Immo Rupf is a Partner at Cinven and co-leader of its global Portfolio Team. His core focus is on Value Creation Plans and Buy-and- Build support for Cinven’s portfolio companies. Specifically for Cinven’s Fund 5, Immo has led the Value Creation Plan initiatives at Amco, Host Europe, Heidelberger Leben, Synlab, Ceramtec, and HotelBeds. And he has supported all major Buy & Build’s in Cinven’s Fund 5: Mercury-Amdipharm (Amco), Heidelberger Leben – Skandia, Host Europe – Domainfactory – TOS, Labco – Synlab.
Follow Immo Rupf:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Maxim Crewe
Partner of Cinven
Maxim leads the Consumer sector team. He is also a member of the UK and Ireland regional team. He has been involved in a number of transactions, including Allegro, Avolon, Guardian Financial Services, Kurt Geiger, NewDay, Partner in Pet Food, Partnership, Planasa and Premium Credit. Previously he worked at Citigroup where he was involved in corporate finance within the European Retail and Consumer Group. Maxim has an MA in Politics, Philosophy and Economics from Oxford University.
Follow Maxim Crewe:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Pontus Pettersson
Partner of Cinven
Pontus joined Cinven in 2011 and is a member of the Industrials sector team. He has been involved in a number of transactions including CeramTec and Prezioso. Previously, Pontus was a Principal at KKR & Co in London, Tokyo and Menlo Park, where he worked on a number of deals. Prior to this, he worked at Altor Equity Partners in Stockholm. ACO Hud, Ferrosan, and Lindorff Group are among the investments on which Pontus worked. Pontus started his career at Goldman Sachs. Pontus has an MA in Politics, Philosophy and Economics from Oxford University and an MBA from the Stanford University Graduate School of Business.
Follow Pontus Pettersson:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Chris Good
Partner of Cinven
Chris joined Cinven in 2006 and is a member of the TMT sector team. He has been involved in a number of investments including Amadeus, CPA Global, Springer and Visma. Previously, Chris worked at Homechoice (Video Networks Ltd) as Senior Manager, Strategy and Planning. Prior to that, he was a consultant at Bain & Company, where he worked across a range of sectors, including business services, retail and telecommunications. Chris has an MSc in Physics from Oxford University.
Follow Chris Good:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Thomas Railhac
Partner of Cinven
Thomas co-leads the TMT sector team and is a member of the regional team for France. He has been involved in a number of transactions, including Allegro, Host Europe Group (‘HEG’), Numericable, One.com, RTB House, Ufinet and Ufinet International. Prior to joining Cinven, Thomas worked in the private equity division of Goldman Sachs (Goldman Sachs Principal Investment Area (‘PIA’)) in London. Thomas has an MSc in Engineering from the Ecole Centrale Paris. He joined Cinven in 2008.
Follow Thomas Railhac:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Lorraine London
Head of Tax and Partnership Services of Cinven
Lorraine is the Head of Tax and Partnership Services and leads the tax team managing Cinven’s carried interest and co-investment schedule. Prior to Cinven, Lorraine was an accountant at the National Coal Board. She is a FCCA certified accountant. She joined Cinven in 1990.
Follow Lorraine London:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Stuart McAlpine
Managing Partner of Cinven
Stuart leads the Business Services and Industrials sector teams. He is also a member of the Healthcare sector team and the UK and Ireland regional team. He has been involved in a number of transactions, including Amadeus, AMCo, CPA Global, Fitness First, Foseco, Medpace, Phadia, Sebia and Unique Pub Company. Stuart was previously with the Royal Bank of Scotland in its Leveraged Finance Group and before that at Ernst & Young in Boston and London. Stuart has a BAcc in Accountancy from Glasgow University. He joined Cinven in 1996.
Follow Stuart McAlpine:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Ivan Kwok
Partner of Cinven
Ivan is a member of the Portfolio team and is responsible for the internationalisation strategy for Cinven’s portfolio companies, active across Cinven’s offices. Previously, Ivan worked at Bain Capital Asia as a Senior Vice President of the Portfolio Group. He was involved in the portfolio management and exits of Feixiang Chemicals and GA Pack. Prior to this, he was a Principal with The Boston Consulting Group for 10 years, leading projects across China, Japan and South East Asia. Ivan received an MBA in Finance from the J.L. Kellogg Graduate School of Management of Northwestern University and an MPhil and a BSc in Sociology from The Chinese University of Hong Kong. He joined Cinven in 2010.
Follow Ivan Kwok:
About Cinven: Cinven is an international private equity firm focused on building world-class global companies.
Pal Erik Sjatil
Global Managing Partner and CEO of Lightrock
Pal Erik Sjatil is the Global Managing Partner and CEO at Lightrock, a global private equity partnership that seeks to achieve financial as well as societal and environmental returns. Lightrock invests in sustainable businesses built by purpose-driven entrepreneurs committed to innovation for systemic change at scale. The company has one of the largest impact-focused growth portfolios in Europe, Latin America and India. More recently, Lightrock has also started building out a portfolio of investments across Sub-Saharan Africa. It invests in companies that pursue scalable and technology-driven business models around the themes people, planet and productivity/tech for good. Specific investment sectors within these themes include education, healthcare, access to finance, mobility, transportation, renewables and circular-economy transition. Lightrock investments demonstrably contribute to the United Nation’s Sustainable Development Goals. Lightrock’s portfolio currently encompasses more than 70 high-growth companies, including Infarm, one of the world’s fastest growing urban farming networks with more than 1200 farms installed; PharmEasy, one of the largest omni-channel healthcare platforms in India; DrConsulta, one of the largest healthcare chains in Latin America; and M-Kopa, a global pioneer for pay-as-you-go solar energy services for off-grid customers in rural East Africa. In 2019, CMR Surgical, a developer of surgical robots that will broaden access to keyhole surgery, was the first of Lightrock’s portfolio companies to become a unicorn – followed by several others, such as Lilium, the sustainable aviation company. As an active owner, Lightrock supports its portfolio companies from a board position in their dynamic growth and expansion phase. Prior to joining Lightrock, Pal Erik Sjatil was a Senior Partner at McKinsey & Company, a member of the firm’s Shareholders Council, and the Managing Partner of McKinsey’s offices in Europe. Before assuming that role, he led McKinsey’s office in Norway, was part of the leadership of the Scandinavian offices, led the office complex in Eastern Europe, and was the Managing Partner of McKinsey’s offices in EEMA (Eastern Europe, Russia/CIS, Turkey, the Middle East, and Africa). Pal Erik also held leadership roles in the firm’s Telecommunications, High Tech, and Strategy & Corporate Finance practices. At McKinsey, he served clients in the telecom, high tech, financial services, and oil and gas industries and focused on corporate strategy, operations, and organizational transformations.
Follow Pal Erik Sjatil:
About Lightrock: Lightrock is a global private equity platform that backs purpose-driven entrepreneurs tackling the world’s biggest challenges.
Nick Moakes
Managing Partner of Investments and Chief Investment Officer of Wellcome Trust
Nick is directly responsible for Wellcome’s global equity, FX and derivatives exposure, as well as playing a key role in broader investment strategy and management of the Investment Team. He is a member of our Investment Committee. Nick joined Wellcome in 2007 from BlackRock Investment Management where he was Head of the Asia Pacific investment team and co-head of Emerging Markets. He has 27 years’ professional experience in Asia, and 22 years’ experience in global equity markets. He graduated in Modern History and Economics from Balliol College, Oxford, and is a CFA charter holder. Before joining BlackRock in 1997, Nick lived in Hong Kong for nine years. He is a Chinese speaker. He started his career in the Diplomatic Service. Nick is Chair of the Imperial College London Endowment Fund and a Non-Executive Director of the Foreign and Colonial Investment Trust. He’s also a Board Member of the UK Investor Forum, which aims to align the interests of listed companies and long-term shareholders.
Follow Nick Moakes:
About Wellcome Trust: Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.
Houman Ashrafian
Managing Partner & Founder of SV Health Investors
Houman Ashrafian is the Managing Partner at SV Health Investors.
Follow Houman Ashrafian:
About Catamaran Bio, Cellinta, Enara Bio, Karus Therapeutics, Sitryx Therapeutics, SV Health Investors, Zarodex Therapeutics: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Kate Bingham
Managing Partner of SV Health Investors
Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed, RespiVert and current investments including Autifony, Bicycle, Convergence, Oncoethix and TopiVert.
Follow Kate Bingham:
About SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Michael Carter
Venture Partner of SV Health Investors
Dr. Michael Carter joined SVLS in 1998 as a Venture Partner. From 1986 to 1998 Michael was on the board of ICI/Zeneca Pharmaceuticals and from 1995 – 1998 was also a board member of Salick Healthcare – a US subsidiary of Zeneca. He was International Marketing Director at ICI/Zeneca Pharmaceuticals; in addition as International Medical Director he was involved in the clinical and commercial development of over 20 new medicines. For 10 years (1986 – 1996) he was a member of the UK Government’s Medicines Commission. He has also worked at Roche Products as Director of the Pharmaceutical Division. Before entering the pharmaceutical industry, Michael practiced as a physician for eleven years. Michael is currently on the boards of GTx Inc, Oxagen / Atopix, Oncoethix, Santarus Inc. and a member of the Strategic Advisory Board of Healthcare Royalty Partners. Previously Dr Carter was on the boards of CancerVax, Genosis, Fulcrum, KuDOS, Micromet and Warner Chilcott.
Follow Michael Carter:
About OncoEthix, SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Hamish Cameron
Venture Partner of SV Health Investors
Hamish Cameron is the Operating Partner at SV Health Investors.
Follow Hamish Cameron:
About Janssen Belgium, SV Health Investors, SV Health Investors: SV Health Investors is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Michail Zekkos
Partner of Permira
Michail is Head of the London office. He focuses on investment opportunities in the Technology sector. He has worked on a number of transactions including Exclusive Group, Findus Italy, Netafim and Teraco. Prior to joining Permira, Michail worked for eight years in technology investment banking at JPMorgan in London.
Follow Michail Zekkos:
About Permira: Permira is a global growth obsessed private capital investor.
Elisabetta Frontini
Operating Partner of Permira
Elisabetta is Head of the Portfolio Group. She is primarily focused on portfolio opportunities in the Consumer sector. She has worked on the Arcaplanet and La Piadineria transactions and currently serves on the boards of both. Elisabetta is a member of the ESG group. Prior to joining Permira, Elisabetta was a Partner at McKinsey & Company where she worked for more than 10 years as a leader in the European Consumer and TMT Practices with clients in Europe, Asia and MEA. After McKinsey & Company, she joined Ferrero Group, where she had various transformational roles in M&A, strategy, development of new businesses and new product development.
Follow Elisabetta Frontini:
About Permira: Permira is a global growth obsessed private capital investor.
Emily Deacon
Life Sciences Partnerships Manager of Huma Therapeutics
Follow Emily Deacon:
About Huma Therapeutics: Huma provides a digital health platform used for predictive care and research.
Adam Jones
Talent Partner – Technology and Product of Huma Therapeutics
Follow Adam Jones:
About Huma Therapeutics: Huma provides a digital health platform used for predictive care and research.
Magnus Jern
Co-founder and Head of Partnerships of TAPP Water
Magnus Jern is a serial entrepreneur, investor, non-exec currently serving as co-founder and head of Partnerships at Tapp Water. Prior to this he was CEO & Founder of Golden Gekko (acquired by DMI in 2014). He has spent the last 17 years as a pioneer with mobile services. His early work included working on groundbreaking digital marketing initiatives for major brands such as Volvo, Ikea, AstraZeneca, Nike and BT. He then spent 5 years creating new products and services for Orange Group in Scandinavia and later Vodafone Group including award winning and industry leading Vodafone live!. He is the founder and co-founder of more than 7 start-ups including Driftbolaget, Lechill Mobile, GeoMe, Golden Gekko, NCOMVa and Tapp Water.
Follow Magnus Jern:
About TAPP Water: TAPP Water has the mission to empower people to easily get clean and healthy water from tap, with a minimum environmental impact.
Jason Ball
Partner of GR Capital
Venture Capital and Angel Investor, focused on Fintech, Foodtech, Health & Wellness and Mobility Previously at Qualcomm Ventures Europe with investments in Arteris (acquired by Qualcomm), Videoplaza (acquired by Ooyala), We7 (acquired by Tesco) and YPlan (acquired by TimeOut). Prior to joining Qualcomm, Jason at London Seed Capital, a seed and early stage venture capital fund, where he focused on material science and software companies, notably leading the firm’s investment in Brandwatch.
Follow Jason Ball:
About GR Capital: A pan-European venture fund with a panoramic view
Adam Rawat
Talent Partner – Technical of Lantum
Follow Adam Rawat:
About Lantum: Lantum is the online platform that enables healthcare providers to manage their clinical workforce.
Mairi Johnson
Chief Partnerships Officer of Babylon
Mairi brings a wealth of knowledge gained from leading equities research analysis within investment banks. She uses her expertise in this field to drive focus on partnerships with international NGOs as Babylon scales its international reach into developing economies.
Follow Mairi Johnson:
About Babylon, Big Issue Invest: Babylon is a world leading, digital-first, value-based care company.
Matthew Foy
Partner of SR One
Follow Matthew Foy:
About Press London, Progenitor Labs, Psioxus Therapeutics, SR One: SR One is the corporate venture capital arm of GlaxoSmithKline.
Andrea Mainardi
Board Member and EMEA Strategic Partnership Manager of Sensoria
Follow Andrea Mainardi:
About : Sensoria designs, develops, and produces body-sensing wearable devices.
Andrea Mainardi
Board Member and EMEA Strategic Partnership Manager of Sensoria
Follow Andrea Mainardi:
About : Sensoria designs, develops, and produces body-sensing wearable devices.
Patrick Round
Venture Partner of Forbion Capital Partners
Before joining NorthSea Therapeutics, Patrick Round was CMO and CEO of Xention Limited which conducted all the development work for Dezima BV which was acquired by Amgen. Before Xention he was Senior Vice President of Development at Cambridge Antibody Technology when it was acquired by Astra Zeneca. He also served as Director of Development at Celltech, Director of Clinical Development at Glaxo Wellcome and started his pharma career as a medical adviser at Novo Nordisk in 1991 in the UK and later in Denmark. He has also worked as CMO for a number of Biotech start-up companies. He received his medical degree from Charing Cross Hospital Medical School in London in 1982, became a Fellow of the Royal College of Anaesthetists in 1990 and a Fellow of the Faculty of Pharmaceutical Medicine in 2005
Follow Patrick Round:
About Forbion Capital Partners, NorthSea Therapeutics: Forbion Capital Partners is a private equity and venture capital firm for making investments in buyouts.
Elena Buchen
Venture Partner of Polar Light Ventures
Elena is a Venture Partner at Polar Light Ventures AG, an investment firm based in Switzerland focusing on early-stage technology ventures. She previously served as an advisor to the Mara Foundation and the Varkey Gems Foundation where she was involved in the implementation of social-impact programmes in Kenya, Uganda and Nigeria. Before her philanthropy engagements, she worked for Roland Berger Strategy Consultants in Russia and Germany. Elena holds a Master of Business Administration and Economics from WHU – Otto Beisheim School of Management in Germany.
Follow Elena Buchen:
About : Principal Investment Company focusing on early stage technology ventures.
Leigh Phillipson
Director of Partnerships of MoveGB
Follow Leigh Phillipson:
About MoveGB: MoveGB allows you to exercise how, when, and where you want.
Sam Gray
Managing Partner of Apposite Capital
Follow Sam Gray:
About Apposite Capital, OrthoD Group: Apposite Capital is a London-based investment firm focused on healthcare services and life sciences companies.
David Davenport-Firth
Managing Partner, Brain Sciences Centre of Ogilvy Health
David Davenport-Firth leads health behaviour strategy and intervention, driving and supporting Ogilvy CommonHealth Worldwide’s position as the health behaviour specialists of Ogilvy. He is a self-confessed ‘quantified selfer’ and is passionate about health data visualisation and wearable technology. He is particularly interested in clinical decision making behaviour and how the psychosocial dimensions of health and illness can be better managed through visualisation and digital engagement. As such, he relishes collaborations with Central Saint Martins, Imperial College London, the University of Oxford Health Experiences Research Group, Warwick Business School the University of Westminster and is an active member of the #ogilvychange community. After working in innovation management and marketing, including two years in the United States, David returned to England to join Coley Porter Bell, becoming Chairman in 2001. He later moved into Ogilvy’s health network and after establishing a consulting offer and re-engineering the digital health practice in London, he switched his focus to behavioural medicine.
Follow David Davenport-Firth:
About Ogilvy Health: Ogilvy Health is a marketing and advertising agency that specializes in the health care industry.
Ashley McKimm
Head of Innovation and Improvement and Director of Partnership Development of BMJ Group
Ashley McKimm is Head of Innovation and Improvement at the British Medical Journal. Ashley practiced as a medical doctor in the UK before being seconded as a Clinical Advisor to the National Health Service medical director, Professor Sir Bruce Keogh. He is Director of the International Forum on Quality and Safety in Healthcare and past chairman of the UK Medical Journalists’ Association.
Follow Ashley McKimm:
About BMJ Group: BMJ Group provides medical information and resources to doctors, researchers, healthcare workers, and patients worldwide.
Sandy Royden
Founding Partner, Joint CEO & COO of OPEN Health
A pharmacist by profession with nearly 25 years’ experience within the industry, Sandy has a great grounding in pharmaceutical marketing at a Global, European and UK domestic level. Prior to OPEN Health, Sandy worked in clinical development, sales, marketing and communications at Novartis and Sanofi, followed by 5 years at Huntsworth Health, where she headed up the European team; managing the integrated brand communications, medical communications and market research offerings. With broad experience across the communications mix, Sandy’s specific areas of focus are market access and medical communications.
Follow Sandy Royden:
About OPEN Health: OPEN Health is a healthcare communications and market access group.
Andy Bell
Partner of OPEN Health
Andy has spent nearly half his life in consumer and pharmaceutical marketing, leaping to the latter in 1999. A copywriter at heart, he believes that everyone has the capacity to be creative, and enjoys nothing more than seeing a group of people find innovation through collaboration. Andy oversees all the creative copy content at LEC London, with a focus on clarity of communication.
Follow Andy Bell:
About OPEN Health, OPEN Health: OPEN Health is a healthcare communications and market access group.
Roger Selman
Founding Financial Partner of OPEN Health
Roger is a Chartered Accountant with 30 years’ experience in the marketing services sector, including his role as Group Finance Director of Shandwick Plc and later Huntsworth Plc, retiring in 2006. In 2007 he became CFO of the healthcare division of Huntsworth, until 2010. As a founding partner of OPEN Health, Roger is directing the finances of the business.
Follow Roger Selman:
About OPEN Health: OPEN Health is a healthcare communications and market access group.
James Bell
Partner & Chief Accountant of OPEN Health
James is a qualified chartered accountant and has been involved with healthcare marketing for over 15 years. Before joining OPEN Health in September 2011 he spent 9 years as the European Finance Director at Huntsworth Health.
Follow James Bell:
About OPEN Health: OPEN Health is a healthcare communications and market access group.
James Fleet
Executive Director & Consulting Partner of Four Eyes Insight
James is a clinical workforce efficiency specialist. James has significant experience in clinical workforce productivity and transformation within Health and works closely with Hospitals to secure sustainable efficiency improvements, optimum productivity and high levels of performance. James has previously worked within the NHS as an Executive Director and also led PwC’s health workforce consulting team, which involved him working with a large range of FT’s and Trust’s, as well as the Department of Health and NHS regulators – Monitor, NTDA and the CQC. James has led the delivery of major efficiency and productivity programmes, with huge success.
Follow James Fleet:
About Four Eyes Insight: Four Eyes Insight is a medical productivity and clinical service consultancy, founded in 2013.
Giga Zulmat
Head of Partnerships of Earthmiles
Follow Giga Zulmat:
About Earthmiles: Track and be rewarded for your healthy and fit activities. Get exclusive deals on the widest range of fitness products.
Amy Burley
Brand & Partnerships Manager of The Medic App
Follow Amy Burley:
About The Medic App: The Medic App gives you the ability to schedule medication reminders and track your adherence.
Dan Zelezinski
Director of Health Partnerships of Biovotion
Dan has recently taken up the role of Director of Health Partnerships for Biovotion. A leading medical grade, wearable technology company headquartered in Zurich. Prior to this, he has an academic background in physiology and applied this in the health and high performance domain, operating for the past 15 years as a consultant within the Goldman Sachs Wellness & Leadership Programmes. His expertise lies in the application of scientific principles to enhance mind and body interconnectedness, to distil and leverage insights afforded by cutting edge sensing technology and ultimately, to drive sustainable high performance. On a personal level, he has been involved in competitive sports most of his life and continues to actively seek opportunities to push limits. He has completed Ironman events, climbed Himalayan peaks, competed in the ACR, billed as the “toughest ski race in the world” – a 180km X Country ski race in the Arctic Circle and has rowed across the Mediterranean, raising $1m for the HPV foundation. He still claims that the hardest challenge is bed and bath time duties for his 4 young children!
Follow Dan Zelezinski:
About Biovotion, Goldman Sachs: Biovotion AG is a digital health company in the field of sophisticated, medical-grade, wearable health monitoring solutions.
Saif Abed
Founding Partner and Director of Cybersecurity Advisory Services of AbedGraham Healthcare Strategies
Saif Abed is the CEO of Clinical Cyber Defense Systems. He is also the founding partner and director of cybersecurity advisory services at AbedGraham.
Follow Saif Abed:
About AbedGraham Healthcare Strategies: Exclusively clinically based, healthcare IT strategy consultancy providing clinical analysis, strategy development, and risk compliance
Lara Morgan
Venture Partner of Scentered
Follow Lara Morgan:
About E2Exchange, Global Amenities Direct, Scentered, Scentered, The Supper Club, Yogi Bare: Scentered is an online shop that offers beauty, health, wellness and aromatherapy products.
Kay Ali
Head of Founding Partners of The Royal Foundation
Follow Kay Ali:
About The Royal Foundation: The Royal Foundation is a non-profit organization that organizes wildlife conservation, young people and mental health programs.
Richard Morgan
Partner & Head of Defence, Security and The Forces of Harrison Clark Rickerbys
Richard Morgan is a Partner & Head of Defence, Security and The Forces at Harrison Clark Rickerbys.
Follow Richard Morgan:
About Harrison Clark Rickerbys: Providing exceptional legal expertise and client care.
